The Regulation contains a number of technical traps and operational friction points that can catch practitioners and clients out. Below are the principal “gotchas” to watch for, with the precise provision references.
Instrument and age‑specific thresholds. Many eligibility criteria require assessments using specific instruments or expert certificates depending on age. For example, an adult or child over 8 with a permanent spinal cord injury must have a permanent neurological deficit classified as grade A to D on the ASIA impairment scale assessed under ISNCSCI and a score of 0 on an ISAFSCI item relating to bladder, bowel or sexual function (s 5(1)). In contrast, a child aged 8 or less can satisfy spinal cord injury eligibility by an ongoing bladder or bowel dysfunction plus a medical certificate by an appropriately qualified specialist stating a permanent neurological deficit (s 5(2)). Misapplying the wrong test for the person’s age cohort can result in a rejected application.
FIM assessments conditional on accreditation and agency approval. The Regulation permits use of the FIM or childrens FIM for eligibility only if the assessor is both accredited by the Australasian Rehabilitation Outcomes Centre and approved by the agency (s 12). If an applicant obtains a FIM assessment from an assessor lacking either accreditation or agency approval, the agency may not accept that assessment for eligibility purposes. This creates a potential bottleneck and a compliance step that must be planned into evidence collection.
Children’s thresholds and reliance on specialist opinion. For young children many thresholds are forward‑looking and rely on an “appropriately qualified medical specialist” providing a certificate or report that an injury is “likely” to cause significant adverse impact or permanent impairment requiring attendant care (see ss 6(3), 9(d), 10(c)). These are predictive medical opinions rather than retrospective instrument scores, and the Regulation defines “relevant medical specialist” for traumatic brain injury in children as a paediatric rehabilitation specialist or paediatric neurologist (s 6(4)). Securing the right specialist and persuasive forward‑looking evidence is therefore essential.
Measurement methods for amputations and burns. Amputation eligibility depends on percentage loss of bone length measured by X‑ray or comparison to the contralateral bone, and where unavailable an estimated knee height may be used (ss 7(2), 8(2)). For full thickness burns the thresholds depend on percentage of total body surface area by age (more than 30% for children under 16, more than 40% for others) or involvement of specific body parts such as both hands, face or genital area, and FIM thresholds for functional ability (s 9). Practitioners must ensure imaging and measurement evidence is properly recorded and comparable to the methods the Regulation specifies.
Provider registration and case coordination. Some services must be provided by a registered provider, for example home modifications and coordination services including case managers (s 21). If a participant’s plan requires such services, selecting an unregistered provider where registration is required could create funding disputes.
Agency approval of occupational therapists. For home and vehicle modification or certain attendant care assessments the Regulation requires the agency to obtain information from “an occupational therapist specialising in home modifications approved by the agency” (s 22). That is a two‑part requirement: appropriate specialization and agency approval. Procuring an occupational therapist without agency approval risks non‑recognition of their advice.
Cost‑effectiveness comparisons and alternative funding sources. The agency must consider whether there is a more cost‑effective way to provide treatment and whether it would be more appropriate to fund the treatment under another scheme (s 20(2)(c)). Applicants who fail to demonstrate why other funding avenues are not available may have funding declined or limited. Evidence of cost comparisons, leasing versus purchase analysis, and cross‑scheme funding assessments should be prepared.
Information sharing breadth. The list of entities the agency may exchange information with in s 14 is broad, including insurers, hospitals, emergency services, employers and educational institutions. Applicants and providers should be aware that sensitive personal information may be shared within that list for the agency’s functions, and prepare privacy consents and data handling precautions accordingly.
Levy non‑refundability. The levy is non‑refundable if a motor vehicle changes to a class with a lower levy or if registration is cancelled (s 25). Vehicle owners who change class mid‑term or cancel registration should be aware they cannot obtain a refund under this Regulation.
Reliance on external instruments. Several eligibility and evidentiary rules depend on instruments and standards produced by third parties, such as the ASIA impairment scale, ISNCSCI, ISAFSCI, Westmead PTA, Glasgow coma scale, FIM instruments and the Snellen scale (see ss 5, 6, 11, 12). If those instrument methodologies are disputed, changed, or applied inconsistently, disputes are likely to arise. Confirmation of current instrument editions and accepted application protocols should be sought.
Non‑exhaustive list of evidence. Sections such as s 18(2) enumerate examples of evidence the agency may consider, for example peer reviewed journal articles or inclusion in clinical guidelines. Those lists are illustrative and may be used to reject novel interventions that lack conventional forms of evidence. Applicants seeking funding for experimental or emerging treatments should prepare to address that evidentiary gap.
In practice these “gotchas” translate into document and process checklists: confirm the correct instrument for the applicant’s age, ensure assessors are accredited and agency‑approved, obtain specialist certificates where required, document measurement methods for amputations and burns, confirm provider registration requirements, prepare cost‑effectiveness evidence, and anticipate information sharing requests. Attention to these technical steps reduces the risk of avoidable administrative rejection or delay.